These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12397406)

  • 1. Risk assessment of chemicals -- the role of epidemiological methods.
    Tarkowski S
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S17-20. PubMed ID: 12397406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and use of epidemiological evidence for environmental health risk assessment: WHO guideline document.
    World Health Organization
    Environ Health Perspect; 2000 Oct; 108(10):997-1002. PubMed ID: 11049823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Environment and health in Gela (Sicily): present knowledge and prospects for future studies].
    Musmeci L; Bianchi F; Carere M; Cori L
    Epidemiol Prev; 2009; 33(3 Suppl 1):7-12. PubMed ID: 19776462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declaring chemicals "not carcinogenic to humans" requires validation, not speculation.
    Melnick RL; Kamel F; Huff J
    Environ Health Perspect; 2003 Apr; 111(4):A203-4. PubMed ID: 12676636
    [No Abstract]   [Full Text] [Related]  

  • 6. Human exposure assessment: finding out what's getting in.
    Wakefield J
    Environ Health Perspect; 2000 Jan; 108(1):A24-6. PubMed ID: 10620534
    [No Abstract]   [Full Text] [Related]  

  • 7. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal Inference Methods for Estimating Long-Term Health Effects of Air Quality Regulations.
    Zigler CM; Kim C; Choirat C; Hansen JB; Wang Y; Hund L; Samet J; King G; Dominici F;
    Res Rep Health Eff Inst; 2016 May; (187):5-49. PubMed ID: 27526497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative health impact assessment: current practice and future directions.
    Veerman JL; Barendregt JJ; Mackenbach JP
    J Epidemiol Community Health; 2005 May; 59(5):361-70. PubMed ID: 15831683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal Impact: Epidemiological Approaches for a Public Health of Consequence.
    Westreich D; Edwards JK; Rogawski ET; Hudgens MG; Stuart EA; Cole SR
    Am J Public Health; 2016 Jun; 106(6):1011-2. PubMed ID: 27153017
    [No Abstract]   [Full Text] [Related]  

  • 12. Nutrient risk assessment: setting upper levels and an opportunity for harmonization.
    Aggett PJ
    Food Nutr Bull; 2007 Mar; 28(1 Suppl International):S27-37. PubMed ID: 17521117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. About hazard and risk assessment: regulatory approaches in assessing safety in the European Union chemicals legislation.
    Gebel T; Lechtenberg-Auffarth E; Guhe C
    Reprod Toxicol; 2009 Sep; 28(2):188-95. PubMed ID: 19631154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic associations between occupational and environmental exposures and autoimmune disease: report of a meeting to explore current evidence and identify research needs.
    Van Loveren H; Vos JG; Germolec D; Simeonova PP; Eijkemanns G; McMichael AJ
    Int J Hyg Environ Health; 2001 Jul; 203(5-6):483-95. PubMed ID: 11556155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From classical epidemiological research to health policy formulation: contribution of Kaunas-Rotterdam Intervention Study.
    Grabauskas V
    Medicina (Kaunas); 2003; 39(12):1184-92. PubMed ID: 14704507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principles of evaluation of public health risk for environmental exposures].
    Bard D
    Rev Epidemiol Sante Publique; 1995; 43(5):423-31. PubMed ID: 7501889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in exposure assessment: the impact on the practice of health risk assessment and epidemiological studies.
    Nieuwenhuijsen M; Paustenbach D; Duarte-Davidson R
    Environ Int; 2006 Dec; 32(8):996-1009. PubMed ID: 16875734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.